Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael Dattoli"'
Publikováno v:
Dose-Response, Vol 18 (2020)
Many scientists and regulators utilize the linear no-threshold (LNT) relationship to estimate the likelihood of carcinogenesis. The LNT model is incorrect and was adopted based upon false pretenses. The use of the model has been corrupted by many to
Externí odkaz:
https://doaj.org/article/fd00f0527de9497ab8ec6a5387a10ee5
Autor:
Kent E. Wallner, L. Christine Fang, Al V. Taira, Lawrence D. True, Michael Dattoli, Richard Sorace
Publikováno v:
Urology. 71:146-150
Objectives To perform a retrospective analysis to assess the utility of pretreatment serum prostatic acid phosphatase (PAP) as a predictor of cause-specific survival (CSS) in patients with higher risk prostate cancer treated with palladium-103 ( 103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fccc496575efc2bff1af8c33458a6fee
https://doi.org/10.1016/j.urology.2007.08.024
https://doi.org/10.1016/j.urology.2007.08.024
Publikováno v:
Cancer. 97:979-983
BACKGROUND The objective of this study was to define the long-term prognostic significance of prostatic acid phosphatase (PAP) levels in patients with higher risk, early-stage prostate carcinoma. METHODS One hundred sixty-one consecutive patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::200b567580dc85cb65c30ff0c76af9c9
https://doi.org/10.1002/cncr.11154
https://doi.org/10.1002/cncr.11154
Publikováno v:
Oncology (Williston Park, N.Y.). 21(8)
Prostatic acid phosphatase (PAP) emerged as the world's first clinically useful tumor marker in the 1940s and 1950s. With the introduction of the prostate-specific antigen (PSA) test in the 1980s, which performed significantly better than PAP in term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0d78b031474244382958413fdc5f7a9
https://pubmed.ncbi.nlm.nih.gov/17715699
https://pubmed.ncbi.nlm.nih.gov/17715699